Characteristics of patients

General hospitalized (n = 110)

Not serious (n = 75)

Severe/critical

(n = 35)

Severe/critical who died (n = 19)

Cause of hospitalization

-Respiratory failure

-Lowered consciousness

-Forner gangrene

-Asthenia

-Gemitus/refusal of food-dyspnea

-dyspnea

-acute influenza

-Hepatopathy

-abdominal pain

-Cellulitis

-Anemia

-chest pain

-DM/HTA decompensation

-Dehydration

-Paludism

-Asymptomatic

25 (22.7%)

8 (7.3%)

1 (0.9%)

13 (11.8%)

1 (0.9%)

19 (17.3%)

27 (24.5%)

6 (5.5%)

3 (2.7%)

1 (0.9%)

1 (0.9%)

1 (0.9%)

1 (0.9%)

1 (0.9%)

1 (0.9%)

1 (0.9%)

0

1 (1.3%)

0

12 (16%)

0

19 (25.3%)

27 (36%)

6 (8%)

3 (4%)

1 (1.3%)

1 (1.3%)

1 (1.3%)

1 (1.3%)

1 (1.3%)

1 (1.3%)

1 (1.3%)

25 (71.4%)

7 (20%)

1 (2.9%)

1 (2.9%)

1 (2.9%)

0

0

0

0

0

0

0

0

0

0

0

13 (68.4%)

5 (26.3%)

1 (5.3%)

0

0

0

0

0

0

0

0

0

0

0

0

0

Average time between clinic onset and hospitalization (days)

4.8 (0 - 14)

5.3 (1 - 14)

4.5 (0 - 10)

4.5 (0 - 10)

T. of symptom onset-hospitalization:

<24 h

48 - 72 h

4 - 7 days

8 - 14 days

Unknown

5 (4.5%)

35 (31.8%)

55 (50%)

13 (11.8%)

2 (1.8%)

3 (4%)

21 (28%)

39 (52%)

10 (13.3%)

2 (2.7%)

2 (5.7%)

14 (40%)

16 (45.7%)

3 (8.6%)

1 (5.3%)

10 (52.6%)

5 (26.3%)

3 (15.8%)

Radiological description:

-Bilateral infiltrate

-Unknown

-Not done

-Normal

-Unilateral infiltrate

39 (35.5%)

10 (9.1%)

57 (51.8%)

2 (1.8%)

2 (1.8%)

22 (29.3%)

0

50 (66.7%)

1 (1.3%)

2 (2.7%)

17 (48.6%)

10 (28.6/)

7 (20%)

1 (2.9%)

0

10 (52.6%)

4 (21.1%)

5 (26.3%)

0

0

Laboratory tests:

-Leukocytosis and lymphopenia

-Normal

-Not done

9 (8.1%)

2 (1.8%)

99 (90%)

4 (5.3%)

2 (2.7%)

69 (92%)

5 (14.3%)

0

30 (85.7%)

5 (26.3%)

0

14 (73.6%)

Antibiotic therapy:

-Ceftriaxone

-Cefotaxime

-Azitromicina

-Clavamox

-Amicacina

-Metronidazol

54 (49.1%)

5 (4.5%)

50 (45.5%)

33 (30%)

2 (1.8%)

6 (5.5%)

20 (26.7%)

2 (2.7%)

29 +1 (40%)

24 +3 (36%)

0

4 (5.3%)

34 (97.1%)

3 (8.6%)

20 (57.1%)

6 (17.1%)

2 (5.7%)

2 (5.7%)

19 (100%)

1 (5.3%)

11 (57.9%)

2 (10.5%)

2 (10.5%)

1 (5.3%)